1,679 filings
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
18 Apr 24
Regulation FD Disclosure
4:06pm
DEFA14A
TEVA
Teva- Pharmaceutical Industries Ltd.
16 Apr 24
Additional proxy soliciting materials
4:16pm
ARS
2023 FY
TEVA
Teva- Pharmaceutical Industries Ltd.
16 Apr 24
Annual report to shareholders
4:12pm
DEF 14A
TEVA
Teva- Pharmaceutical Industries Ltd.
Definitive proxy
16 Apr 24
4:10pm
10-K
2023 FY
TEVA
Teva- Pharmaceutical Industries Ltd.
Annual report
12 Feb 24
7:01am
8-K
0fgwd6m8u816fbi3y
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
5jx0t3bje
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
ohnq48vg8bv3k7yio8nq
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
3u2ucgga4j nobo4brim
28 Sep 23
Teva Announces Changes to Executive Management Team
4:05pm
8-K
f0g4ihu 056g3s
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
gj9ptrf3e5g0vh4
2 Aug 23
Departure of Directors or Certain Officers
4:16pm
8-K
mx4b0n
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
mkweytz2ohclkd0a1e
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
rsrjpq2 5o
8 Jun 23
Teva Concludes Nationwide Opioids Settlement Agreement
8:30am
DEFA14A
mignz rvyqgwwn8rz
24 May 23
Additional proxy soliciting materials
4:01pm
SD
3pkk3ga
24 May 23
Conflict minerals disclosure
12:00am
8-K
2h3di rorl8
11 May 23
Departure of Directors or Certain Officers
4:00pm